PERSEPHONE: 6 versus 12 months (m) of adjuvant trastuzumab in patients (pts) with HER2 positive (+) early breast cancer (EBC): Randomised phase 3 non-inferiority trial with definitive 4-year (yr) disease-free survival (DFS) results.

被引：39

作者：

Earl, Helena Margaret

Hiller, Louise

Vallier, Anne-Laure

Loi, Shrushma

Howe, Donna

Higgins, Helen B.

McAdam, Karen

Hughes-Davies, Luke

Harnett, Adrian Nigel

Ah-See, Mei-Lin

Simcock, Richard

Rea, Daniel William

Mansi, Janine

Abraham, Jean

Caldas, Carlos

Hulme, Claire

Miles, David

Wardley, Andrew M.

Cameron, David A.

Dunn, Janet

机构：

[1] Univ Cambridge, Dept Oncol, Cambridge, England

[2] Univ Cambridge, NIHR Cambridge Biomed Res Ctr, Cambridge, England

[3] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Breast Canc Res Unit, Cambridge, England

[4] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England

[5] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England

[6] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England

[7] Norfolk & Norwich Univ Hosp, Dept Oncol, Norfolk, England

[8] Mt Vernon Canc Ctr, Med Oncol, London, England

[9] Brighton & Sussex Univ Hosp NHS Trust, Sussex Canc Ctr, Brighton, E Sussex, England

[10] Univ Birmingham, Canc Res UK Clin Trials Unit CRCTU, Birmingham, W Midlands, England

[11] Guys & St Thomas NHS Fdn Trust, London, England

[12] Kings Coll Med Sch, London, England

[13] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Cambridge, England

[14] Univ Leeds, Acad Unit Hlth Econ, Leeds, W Yorkshire, England

[15] Univ Manchester, Div Canc Sci, Fac Biol Med & Hlth, Manchester, Lancs, England

[16] Univ Edinburgh, Canc Res UK Edinburgh Ctr, Edinburgh, Midlothian, Scotland

[17] Warwick Clin Trials Unit, Coventry, W Midlands, England

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.506

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

506

引用

页数：1